Literature DB >> 10720724

Toxicity of drug abuse--amphetamine designer drugs (ecstasy): mental effects and consequences of single dose use.

J Mørland1.   

Abstract

MDMA (3,4-methylendioxymethamphetamine) is the most commonly used substance within the 'ecstasy' group of drugs. MDMA interferes with serotonin and catecholamine transporters in the central nervous system to increase monoamine synaptic levels and thereby mediate the majority of its central nervous effects. These range from wanted effects like euphoria, central nervous stimulation, and feeling of closeness to mild hallucinations, impairment of cognition and co-ordination and further to serious reactions like agitation, disturbed and bizarre behaviour, and possibly psychosis. The full picture of the consequences of these transitory changes is not known. It has been assumed that the risk of being involved in fatalities and accidents during the state of MDMA influence is increased, but this possible risk increase has so far not been determined. Observations of the prevalence of MDMA involvement in cases of reckless driving and the MDMA blood concentrations measured indicate a risk increase comparable to that observed after use of amphetamines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720724     DOI: 10.1016/s0378-4274(99)00217-9

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  7 in total

1.  Just the berries. Ecstasy.

Authors:  Lesley Ruggles
Journal:  Can Fam Physician       Date:  2002-03       Impact factor: 3.275

Review 2.  Animal models of schizophrenia: a critical review.

Authors:  E R Marcotte; D M Pearson; L K Srivastava
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

3.  Role of the endocannabinoid system in MDMA intracerebral self-administration in rats.

Authors:  Daniela Braida; Mariaelvina Sala
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

4.  Do adolescent ecstasy users have different attitudes towards drugs when compared to marijuana users?

Authors:  Silvia S Martins; Carla L Storr; Pierre K Alexandre; Howard D Chilcoat
Journal:  Drug Alcohol Depend       Date:  2007-12-18       Impact factor: 4.492

Review 5.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

6.  Perceived risk associated with ecstasy use: a latent class analysis approach.

Authors:  S S Martins; R G Carlson; P K Alexandre; R S Falck
Journal:  Addict Behav       Date:  2011-01-20       Impact factor: 3.913

7.  The association of ecstasy use and academic achievement among adolescents in two U.S. national surveys.

Authors:  Silvia S Martins; Pierre K Alexandre
Journal:  Addict Behav       Date:  2008-08-03       Impact factor: 3.913

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.